Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
cyclophosphamide (cytoxan) (3 trials)
prednisone (meticorten) (3 trials)
vinblastine (velban) (1 trial)
dacarbazine (dtic-dome) (2 trials)
doxorubicin (Doxil) (1 trial)
etoposide (vepesid) (1 trial)
fludeoxyglucose f-18 (1 trial)
procarbazine (matulane) (1 trial)
vincristine (oncovin) (2 trials)
Hodgkin Disease (Phase 4)
Lymphoma (Phase 4)
Trials (3 total)
Trial APIs (9 total)